Lexeo, Abivax File for IPOs on Nasdaq Amid Industry-Wide Drought

Genetic medicines biotech Lexeo Therapeutics and immune-focused French company Abivax both filed for their initial public offerings on Friday. Neither company specified how much they were seeking to raise in their respective SEC filings.